St. John's Wort 300 mg
Product analysis
St. John's Wort 300 mg is a mood supplement whose evidence comes from specific extracts used in people with diagnosed depression. It can weaken many medicines and interact with medicines that affect serotonin, making medication use a key suitability concern.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
Hypericin is identified, but that alone does not establish the quality of the extract. A clear absorption advantage cannot be confirmed.
Ingredient Transparency100
The serving amount is stated, allowing amount comparisons. Hypericin standardization provides another way to distinguish extracts.
Value For Money40
The value of the extract remains uncertain. A stated amount and hypericin detail do not establish a price advantage.
Customer Satisfaction86
Customer ratings are generally positive. Feedback from 5,744 ratings gives a broad picture of satisfaction.
Product Focus55
The single-herb formula focuses on mood support, with evidence tied to particular extracts and clinical settings. One 300 mg serving does not by itself match the 900 mg daily regimen behind those findings.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.12
- Also available
St. John's Wort 300 mg$14.00- Customer rating
- 4.6 · 5,744 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
St. John's Wort Flowering Tops Extract (Hypericin) | 300 mg |
How this ingredient is rated
Composition and Label Disclosure
Composition and Label Disclosure100
Explicit Label Detail
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- St John's wort for major depression.
- Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
- A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
- Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
- Complementary therapies for clinical depression: an overview of systematic reviews.
- Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.
- Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
- Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
- Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
- Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.